001     274068
005     20250115165652.0
024 7 _ |a 10.1111/adb.70009
|2 doi
024 7 _ |a pmid:39764698
|2 pmid
024 7 _ |a pmc:PMC11705499
|2 pmc
024 7 _ |a 1355-6215
|2 ISSN
024 7 _ |a 1369-1600
|2 ISSN
037 _ _ |a DZNE-2025-00049
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Hakus, Aileen
|0 P:(DE-2719)9003240
|b 0
|u dzne
245 _ _ |a Sex-associated differences in incentive salience and drinking behaviour in a rodent model of alcohol relapse.
260 _ _ |a Hoboken, NJ [u.a.]
|c 2025
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736940922_13620
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The ability of environmental cues to trigger alcohol-seeking behaviours is thought to facilitate problematic alcohol use. Individuals' tendency to attribute incentive salience to cues may increase the risk of addiction. We sought to study the relationship between incentive salience and alcohol addiction using non-preferring rats to model the heterogeneity of human alcohol consumption, investigating both males and females. Adult rats were subjected to the alcohol deprivation effect (ADE) paradigm, where they were given voluntary access to different alcohol solutions with repeated interruptions by deprivation and reintroduction phases over a protracted period (five Alcohol Deprivation Cycles). Before each Alcohol Deprivation Cycle, rats were tested in the Pavlovian Conditioned Approach (PCA) paradigm, which quantifies the individual salience toward a conditional cue and the reward, thus allowing us to trace the process of attributing incentive salience to reward cues. During the final Alcohol Deprivation Cycle (ADE5), animals were tested for compulsive-like behaviour using quinine taste adulteration. We investigated sex differences in drinking behaviour and PCA performance. We observed thatb females drank significantly more alcohol than males and displayed more sign-tracking (ST) behaviour in the PCA, whereas males showed goal-tracking (GT) behaviour. Furthermore, we found that high drinkers exhibited more ST behaviour. The initial PCA phenotype was correlated with later alcohol consumption. Our findings indicate a complex relationship between incentive salience and alcohol addiction and emphasize the importance of considering both sexes in preclinical research.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Pavlovian conditioned approach
|2 Other
650 _ 7 |a alcohol addiction
|2 Other
650 _ 7 |a alcohol deprivation effect model
|2 Other
650 _ 7 |a goal tracker
|2 Other
650 _ 7 |a incentive salience
|2 Other
650 _ 7 |a sign‐tracker
|2 Other
650 _ 7 |a Ethanol
|0 3K9958V90M
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Rats
|2 MeSH
650 _ 2 |a Motivation
|2 MeSH
650 _ 2 |a Cues
|2 MeSH
650 _ 2 |a Conditioning, Classical: physiology
|2 MeSH
650 _ 2 |a Alcoholism: physiopathology
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Alcohol Drinking: psychology
|2 MeSH
650 _ 2 |a Reward
|2 MeSH
650 _ 2 |a Recurrence
|2 MeSH
650 _ 2 |a Behavior, Animal
|2 MeSH
650 _ 2 |a Sex Factors
|2 MeSH
650 _ 2 |a Sex Characteristics
|2 MeSH
650 _ 2 |a Ethanol: pharmacology
|2 MeSH
700 1 _ |a Foo, Jerome Clifford
|b 1
700 1 _ |a Casquero-Veiga, Marta
|0 0000-0003-0859-9495
|b 2
700 1 _ |a Gül, Asude Zülal
|b 3
700 1 _ |a Hintz, Franziska
|b 4
700 1 _ |a Rivalan, Marion
|b 5
700 1 _ |a Winter, York
|b 6
700 1 _ |a Priller, Josef
|0 P:(DE-2719)2811122
|b 7
|u dzne
700 1 _ |a Hadar, Ravit
|b 8
700 1 _ |a Winter, Christine
|b 9
773 _ _ |a 10.1111/adb.70009
|g Vol. 30, no. 1, p. e70009
|0 PERI:(DE-600)1495537-4
|n 1
|p e70009
|t Addiction biology
|v 30
|y 2025
|x 1355-6215
856 4 _ |u https://pub.dzne.de/record/274068/files/DZNE-2025-00049%20SUP.docx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/274068/files/DZNE-2025-00049.pdf
856 4 _ |u https://pub.dzne.de/record/274068/files/DZNE-2025-00049%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/274068/files/DZNE-2025-00049%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/274068/files/DZNE-2025-00049%20SUP.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/274068/files/DZNE-2025-00049.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:274068
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-2719)9003240
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2811122
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-22
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ADDICT BIOL : 2022
|d 2023-08-22
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-08-22
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-22
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-22
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-22
920 1 _ |0 I:(DE-2719)5000007
|k AG Priller
|l Translational Neuropsychiatry
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000007
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21